Zolpidem Tartrate

Overview

Zolpidem Tartrate is a sedative-hypnotic used in the short-term treatment of insomnia. It is an imidazopyridine derivative that enhances GABA receptor activity, facilitating sleep.

API suppliers (19)

Suppliers of Zolpidem Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Orchid Pharma LimitedIndia1 active DMF GMP on record
• HOLIDAY LABS MEXICO SA DE CV1 active DMF
• CZECH-GEN AS1 active DMF
• TAPI NL BVNetherlands1 active DMF
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF GMP on record
• DR REDDYS LABORATORIES LTD1 active DMF GMP on record
• Wockhardt UsaUnited Kingdom1 active DMF
• AARTI DRUGS LTDIndia1 active DMF GMP on record
• Sanofi Winthrop IndustrieFrance1 active DMF GMP on record
• YUNG ZIP CHEMICAL IND CO LTD1 active DMF
• SYNTHELABO BP
• Teva Pharmaceutical Industries Ltd.Israel GMP on record
• Cadila Pharmaceuticals LimitedIndia GMP on record
• QUIMICA SINTETICA SASpain GMP on record
• Cadila Healthcare LimitedIndia
• ZENTIVA KSCzechia GMP on record
• BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGGermany
• LABORATOIRES DETUDES ET DE RECHERCHES SYNTHELABO
• SynthonNetherlands GMP on record

EU CEP holders (14)

Companies holding a valid EU Certificate of Suitability (CEP) for Zolpidem Tartrate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas